Short description
RenalytixAI is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney health.
Description
RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, and patient stratification for drug clinical trials.
RenalytixAI’s technology platform will draw from distinct sources of patient data, including large electronic health records, predictive blood-based biomarkers, and other genomic information for analysis by learning computer algorithms. RenalytixAI intends to build a deep, unique pool of kidney disease-related data for different AI-enabled applications designed to improve predictive capability and clinical utility over time.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Penarth, Vale of Glamorgan, The, United Kingdom, Europe
Founded on
January 1, 2018
Exited on
November 6, 2018
Went public on
November 6, 2018
Stock symbol
RENX
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe, Noaccess, Uh Ohhhh, Cannot Access, Noaccess, Noaccess
Sign in for full access
Founders
Girish Nadkarni, James R. McCullough, Steven Coca